42.35
+0.20
+(0.47%)
At close: 1:30:26 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,000.00
1,000.00
1,000.00
550.00
617.00
Cost of Revenue
488.00
448.00
495.00
227.00
266.00
Gross Profit
512.00
552.00
505.00
323.00
351.00
Operating Expense
311,130.00
311,663.00
356,620.00
346,639.00
359,610.00
Operating Income
-310,618.00
-311,111.00
-356,115.00
-346,316.00
-359,259.00
Net Non Operating Interest Income Expense
5,636.00
7,106.00
6,771.00
4,088.00
3,760.00
Pretax Income
-295,946.00
-295,045.00
-348,260.00
-328,347.00
-354,382.00
Tax Provision
1,261.00
1,261.00
1,372.00
910.00
496.00
Net Income Common Stockholders
-297,207.00
-296,306.00
-349,632.00
-329,257.00
-354,878.00
Diluted NI Available to Com Stockholders
-297,207.00
-296,306.00
-349,632.00
-329,257.00
-354,878.00
Basic EPS
-3.33
-3.32
-3.92
-3.67
-4.49
Diluted EPS
-3.33
-3.32
-3.92
-3.67
-4.49
Basic Average Shares
89,189.43
89,186.00
89,190.00
89,642.00
78,986.00
Diluted Average Shares
89,189.43
89,186.00
89,190.00
89,642.00
78,986.00
Total Expenses
311,618.00
312,111.00
357,115.00
346,866.00
359,876.00
Net Income from Continuing & Discontinued Operation
-297,207.00
-296,306.00
-349,632.00
-329,257.00
-354,878.00
Normalized Income
-297,207.00
-296,306.00
-349,632.00
-329,257.00
-354,878.00
Interest Income
6,245.00
7,641.00
7,315.00
4,614.00
4,019.00
Interest Expense
609.00
535.00
544.00
526.00
259.00
Net Interest Income
5,636.00
7,106.00
6,771.00
4,088.00
3,760.00
EBIT
-295,337.00
-294,510.00
-347,716.00
-327,821.00
-354,123.00
EBITDA
-283,466.00
-283,785.00
-340,604.00
-321,587.00
-347,012.00
Reconciled Cost of Revenue
488.00
448.00
495.00
227.00
266.00
Reconciled Depreciation
11,871.00
10,725.00
7,112.00
6,234.00
7,111.00
Net Income from Continuing Operation Net Minority Interest
-297,207.00
-296,306.00
-349,632.00
-329,257.00
-354,878.00
Normalized EBITDA
-283,466.00
-283,785.00
-340,604.00
-321,587.00
-347,012.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
12/31/2020 - 12/4/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
3205.TWO Sagittarius Life Science Corp
33.95
-1.59%
4167.TWO Savior Lifetec Corporation
19.75
-0.25%
3176.TWO Medigen Biotechnology Corp.
32.60
-1.21%
4162.TWO PharmaEngine, Inc.
95.10
+2.15%
6541.TW Tanvex BioPharma, Inc.
65.30
+3.98%
4130.TWO Genovate Biotechnology Co., Ltd.
25.30
+1.81%
4133.TW Abnova (Taiwan) Corporation
29.80
-1.16%
4147.TWO TaiMed Biologics Inc.
86.50
+0.35%
6589.TWO EirGenix Inc.
79.80
+1.01%
4171.TWO GeneReach Biotechnology Corp.
28.40
-1.05%